Phosphoramidite Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Phosphoramidite Market is Segmented by Type (DNA Phosphoramidites, RNA Phosphoramidites, and Other Phosphoramidites), End-User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Other End-Users), and Geography (North America, Europe, Asia-Pacific, and Rest of the World). The Report Offers the Value in USD for the Above Segments.

Phosphoramidite Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Phosphoramidite Market Size

Phosphoramidite Market Size
Study Period 2019 - 2030
Base Year For Estimation 2024
Market Size (2025) USD 1.20 Billion
Market Size (2030) USD 1.64 Billion
CAGR (2025 - 2030) 6.42 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Phosphoramidite Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Phosphoramidite Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Phosphoramidite Market Analysis

The Phosphoramidite Market size is estimated at USD 1.20 billion in 2025, and is expected to reach USD 1.64 billion by 2030, at a CAGR of 6.42% during the forecast period (2025-2030).

At the start of the COVID-19 pandemic, most businesses and research activities around the world ceased due to the increasing rate of infection from the SARS-CoV-2 virus, which reduced the use and demand of gene synthesizers like phosphoramidite in laboratories in the market. However, gene synthesizers played a crucial role in the research and development of the mRNA-based COVID-19 vaccine, which eventually increased the demand for phosphoramidite in the market. For example, in January 2022, the Food and Drug Administration provided a second approval to the mRNA-based COVID-19 vaccine from Moderna called Spikevax. Therefore, such developments increased the demand for phosphoramidite during the pandemic.

  • The factors responsible for the growth of the phosphoramidite market include increasing synthetic nucleotide applications in therapeutics, growth in synthetic biology, and therapeutics for different chronic diseases. Also, governments of various nations have been providing research support for synthetic biology because of its extensive applications. For instance, in September 2022, the Government of New South Wales announced an investment of over USD 6 million into a new synthetic biology and biomanufacturing development program, which would improve access to manufacturing and production facilities and equipment across the State of Wales, Australia.
  • Furthermore, increasing product launches and approvals are expected to increase the demand for phosphoramidite synthesis, propelling the market growth. For instance, in June 2021, DNA Script launched the Syntax platform with its Syntax System, an Enzymatic DNA Synthesis (EDS) technology-powered benchtop nucleic acid printer. The Syntax System comprises up to 60 nucleotides in length and delivers ready-for-use in d genomics workflows and molecular biology without additional handling. The system enables DNA oligos to be printed on-demand at record speed and without the delays or backorders that can occur with outsourced phosphoramidite synthesis services. Such instances are expected to propel the market's growth over the forecast period.
  • However, challenges in developing long nucleotide sequences are expected to hinder the market's growth.

Phosphoramidite Industry Overview

The phosphoramide market is moderately competitive and consists of several major players. In terms of market share, a few of the major players Thermo Fisher Scientific, Biosynth Carbosynth, TriLink BioTechnologies, Bioneer Corporation, Hongene Biotech Corporation and others, are currently dominating the industry.

Phosphoramidite Market Leaders

  1. Thermo Fisher Scientific

  2. Biosynth Carbosynth

  3. TriLink BioTechnologies

  4. Bioneer Corporation

  5. Hongene Biotech Corporation

  6. *Disclaimer: Major Players sorted in no particular order
Phosphoramidite Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Phosphoramidite Market News

  • March 2023: Oligo Factory, an independent custom oligonucleotide manufacturer, opened a new oligo manufacturing facility with 13,000 sq ft of combined offices, bench space, and labs in Holliston, United States.
  • July 2022: WuXi STA launched a new large-scale oligonucleotide and peptide manufacturing facility at its Changzhou campus. This new launch enhances its capacity and capability to meet the fast-growing customer needs for oligonucleotide and peptide therapeutics development and manufacturing worldwide.

Phosphoramidite Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Synthetic Nucleotide Applications in Therapeutics
    • 4.2.2 Growth in Synthetic Biology
  • 4.3 Market Restraints
    • 4.3.1 Challenges in Developing Long Nucleotide Sequences
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD)

  • 5.1 By Type
    • 5.1.1 DNA Phosphoramidites
    • 5.1.2 RNA Phosphoramidites
    • 5.1.3 Other Phosphoramidites
  • 5.2 By End-User
    • 5.2.1 Pharmaceutical and Biotechnology Companies
    • 5.2.2 Academic and Research Institutes
    • 5.2.3 Other End-Users
  • 5.3 Geography
    • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
    • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Rest of the World

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Thermo Fisher Scientific Inc.
    • 6.1.2 Biosynth Ltd
    • 6.1.3 TriLink BioTechnologies
    • 6.1.4 Bioneer Corporation
    • 6.1.5 Hongene Biotech Corporation
    • 6.1.6 Tokyo Chemical Industry Pvt. Ltd.
    • 6.1.7 Danaher Corporation
    • 6.1.8 Creative Biolabs, Inc.
    • 6.1.9 PolyOrg, Inc.
    • 6.1.10 Lumiprobe Corporation
    • 6.1.11 QIAGEN N.V.
    • 6.1.12 BOC Sciences
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Phosphoramidite Industry Segmentation

Phosphoramidites are modified nucleosides and are a standard chemical utilized in modern DNA synthesis. Phosphoramidites permit the sequential addition of new bases to the DNA chain in an exquisitely simple and exceptionally efficient cyclic reaction.

The phosphoramidite market is segmented by type, end-user, and geography. By type, the market is segmented into DNA phosphoramidites, RNA phosphoramidites, and other phosphoramidites. By end-user, the market is segmented into pharmaceutical and biotechnology companies, academic and research institutes, and other end users. The report also covers the market sizes and forecasts for the phosphoramidite market in major countries across different regions. For each segment, the market size is provided in terms of value (USD).

By Type DNA Phosphoramidites
RNA Phosphoramidites
Other Phosphoramidites
By End-User Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Other End-Users
Geography North America United States
Canada
Mexico
Geography Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Geography Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Geography Rest of the World
Need A Different Region or Segment?
Customize Now

Phosphoramidite Market Research Faqs

How big is the Phosphoramidite Market?

The Phosphoramidite Market size is expected to reach USD 1.20 billion in 2025 and grow at a CAGR of 6.42% to reach USD 1.64 billion by 2030.

What is the current Phosphoramidite Market size?

In 2025, the Phosphoramidite Market size is expected to reach USD 1.20 billion.

Who are the key players in Phosphoramidite Market?

Thermo Fisher Scientific, Biosynth Carbosynth, TriLink BioTechnologies, Bioneer Corporation and Hongene Biotech Corporation are the major companies operating in the Phosphoramidite Market.

Which is the fastest growing region in Phosphoramidite Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Phosphoramidite Market?

In 2025, the North America accounts for the largest market share in Phosphoramidite Market.

What years does this Phosphoramidite Market cover, and what was the market size in 2024?

In 2024, the Phosphoramidite Market size was estimated at USD 1.12 billion. The report covers the Phosphoramidite Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Phosphoramidite Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Phosphoramidite Industry Report

Statistics for the 2025 Phosphoramidite market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Phosphoramidite analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.